How do you taper tirzepatide or semaglutide to maintenance?
No label we checked for tirzepatide (Mounjaro, Zepbound) or semaglutide (Wegovy, Ozempic) gives a taper schedule. Tirzepatide's maintenance doses are 5, 10 or 15 mg weekly; Wegovy's are 2.4 mg, or 1.7 mg on the US label. In one trial, cutting tirzepatide to 5 mg kept off more weight than placebo, though less than the highest tolerated dose.
What maintenance doses do the labels list?
The US Zepbound label lists tirzepatide 5, 10 or 15 mg once a week, chosen by response and how well it is tolerated.1
The 2.5 mg start dose is not a maintenance dose. Doses rise in 2.5 mg steps, at least 4 weeks apart, up to 15 mg.1 The EU Mounjaro SmPC lists the same three maintenance doses.4 If a maintenance dose is not tolerated, the US Zepbound label says to consider a lower one.1
For weight, the US Wegovy label lists semaglutide 1.7 mg or 2.4 mg a week, with 2.4 mg recommended. After at least 4 weeks on 2.4 mg, it allows up to 7.2 mg.2 Ozempic, the diabetes brand, is kept at 0.5, 1 or 2 mg a week, set by blood sugar.3
Side effects were common at every maintenance dose. In the Zepbound weight trials, 25 in 100 people felt sick on 5 mg and 28 in 100 on 15 mg, against 8 in 100 on placebo.1 Stomach side effects made 1.9 in 100 stop on 5 mg and 4.3 in 100 on 15 mg, against 0.5 in 100 on placebo.1
Do the labels say how to taper off?
No label we searched sets out a schedule for tapering off; the dosing sections cover stepping up, staying on a dose and missed doses.1245
A lower dose appears only for side effects. The EU Wegovy SmPC says that with significant stomach symptoms, going back to the previous dose until they improve could be considered.5
Every injected dose on these labels is once a week.1245 A missed tirzepatide dose can be taken within 4 days; after that, it is skipped.1 For Wegovy the window is 5 days.5 If 2 or more Wegovy doses in a row are missed, the US label says to restart the dose steps at a lower dose.2
The US Zepbound label gives tirzepatide's half-life (the time for half of it to clear) as about 5 to 6 days.1 We found no published trial comparing a gradual taper with stopping at once.
What happened to weight when people cut the dose or stopped?
In SURMOUNT-MAINTAIN, cutting tirzepatide to 5 mg kept off more weight than switching to placebo, but less than staying on the highest tolerated dose.14
All 378 people first took 10 or 15 mg for 60 weeks. At week 112, total loss was 21.9% on the full dose, 16.6% on 5 mg and 9.9% on placebo. Lilly funded the trial.14 For a 100 kg person, those averages are about 22, 17 and 10 kg. The authors note that responses to the lower dose might vary.14
Stopping brought more regain. In SURMOUNT-4, weight fell a further 5.5% over 52 weeks on tirzepatide and rose 14.0% on placebo.11 In STEP 4, it fell 7.9% over 48 weeks on semaglutide 2.4 mg and rose 6.9% on placebo.12 A year after stopping semaglutide in the STEP 1 extension, people had regained two-thirds of their loss.13
The US Zepbound label describes its use as reducing excess weight and keeping it off long term.1 Our side effects guide covers the risks of staying on treatment.
What do people on GLP-1 medicines report about maintenance doses and tapering?
From public patient forums: 1,358 Reddit threads in r/Zepbound, r/mounjarouk, r/GLPGrad, r/Mounjaro, r/MounjaroMaintenance and r/mounjaromaintenanceuk, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Several say there was no standard maintenance dose, and they found theirs by trial and error, sometimes over months. The US Zepbound label says to choose by response and tolerability.1
- Matches the trial Several say lowering the dose brought back hunger, food noise or some regain, and some went back up a step. In SURMOUNT-MAINTAIN, people cut to 5 mg kept off less weight than those on the full dose. The trial measured weight, not hunger.14
- Matches the trials Several stopped and regained, sometimes fast, while several others held their weight for months, usually after tapering and close tracking. On average, people in the withdrawal trials regained weight after stopping.1113
- Label says otherwise Many describe stretching the gap between injections beyond a week, and several say it brought hunger late in the cycle or worse side effects after each shot. The tirzepatide labels set once-weekly doses, and a missed dose is skipped after 4 days.14
Advice people share
- Not studied Several advise stepping down slowly, one dose level at a time, holding each step for weeks. We found no published trial comparing a gradual taper with stopping at once.
- Matches the label Several advise treating it as long-term treatment and expecting regain on stopping. The US Zepbound label is for keeping weight off long term, and SURMOUNT-4 found regain after stopping.111
- Label says otherwise Many describe taking partial or in-between doses from multi-dose pens. The labels give set doses, raised in 2.5 mg steps for tirzepatide.14
In your country
Every label we opened gives once-weekly maintenance doses and no taper schedule, but the rules for semaglutide 1.7 mg and 7.2 mg differ, and the UK adds a 5% check.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The Australian Wegovy Product Information makes 2.4 mg the maintenance dose. If 2.4 mg is not tolerated, 1.7 mg can be used for maintenance, going back to 2.4 mg if tolerated. It allows 7.2 mg for adults whose BMI was 30 or more at the start, lowered to 2.4 mg if weight does not improve further.10 The Australian Mounjaro Product Information states that 2.5, 7.5 and 12.5 mg are not maintenance doses.9
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: The Canadian Wegovy monograph makes 2.4 mg the maintenance dose for adults. If it is not tolerated, the dose can drop to 1.7 mg for at most 4 weeks, then go back up to 2.4 mg.8
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Wegovy SmPC makes 2.4 mg the maintenance dose and does not list 1.7 mg as one. It allows 7.2 mg for adults whose BMI was 30 or more at the start, reduced to 2.4 mg if weight does not improve further.5
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Wegovy SmPC makes 2.4 mg the maintenance dose and does not list 1.7 mg as one. It allows 7.2 mg for adults whose BMI was 30 or more at the start, reduced to 2.4 mg if weight does not improve further.5
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not open an Indian label for this page, so this answer relies on the US labels and EU product summaries.1245
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a Saudi label for this page, so this answer relies on the US labels and EU product summaries.1245
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open a UAE label for this page, so this answer relies on the US labels and EU product summaries.1245
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK SmPCs add a 5% check for weight management. On Mounjaro, it comes 6 months after reaching the highest tolerated dose. On Wegovy, it comes after 6 months of treatment. Anyone who has not lost at least 5% of their starting weight by then needs a decision on continuing.67
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if you have severe stomach pain that may spread to your back, nausea, vomiting or diarrhoea that does not go away, or signs of gallbladder problems such as upper stomach pain, fever or yellowing of the skin or eyes.1
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly. uspl.lilly.com
- US Wegovy (semaglutide) prescribing information, Novo Nordisk, on DailyMed. dailymed.nlm.nih.gov
- US Ozempic (semaglutide) prescribing information, Novo Nordisk. novo-pi.com
- EU Mounjaro product information (SmPC), European Medicines Agency. ema.europa.eu
- EU Wegovy product information (SmPC), European Medicines Agency. ema.europa.eu
- UK Mounjaro KwikPen SmPC, electronic Medicines Compendium. medicines.org.uk
- UK Wegovy 2.4 mg FlexTouch SmPC, electronic Medicines Compendium. medicines.org.uk
- Canadian Wegovy (semaglutide) Product Monograph. pdf.hres.ca
- Australian Mounjaro Product Information. medsinfo.com.au
- Australian Wegovy Product Information. medsinfo.com.au
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA, 2024. doi.org
- Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA, 2021. doi.org
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. 2022. pubmed.ncbi.nlm.nih.gov
- Horn DB, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity (SURMOUNT-MAINTAIN). Lancet, 2026. Funded by Eli Lilly. doi.org
- American College of Emergency Physicians. Know When to Go to the ER. emergencyphysicians.org
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write